DANIELLE GRISANTI: Open Payments
NPI 1538469804 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 76 payments from 15 companies in 2025. Trend: 2023 $2,835 · 2024 $1,661 · 2025 $1,377
Food & beverage: $1,377
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $503 |
| Teva Pharmaceuticals USA, Inc. | 23 | $338 |
| Neurocrine BioSciences, Inc. | 6 | $96 |
| UCB, Inc. | 4 | $94 |
| SK Life Science, Inc. | 3 | $62 |
| PFIZER INC. | 3 | $54 |
| Merz Pharmaceuticals, LLC | 2 | $39 |
| Lundbeck LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $25 |
Products named: AUSTEDO XR, UBRELVY, BOTOX, INGREZZA, Nayzilam, QULIPTA, VYALEV, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
